EQT Reportedly Nearing QIAGEN Offer at €46.50 a Share
Bloomberg reports QIAGEN’s supervisory board may soon back EQT’s proposed bid, though no final decision has been made.
Makkler Newsroom · Oct 22, 06:37 AM · 1 min read
QIAGEN NV QGEN
NYSEHealth TechnologyUnited States
$49.89-0.21 (-0.42%)
Market closed· · USD · Data may be delayed
- Day's range
- 49.8350.10
- 52-week range
- 32.5357.82
Financial health
– / 5
Analyst view · 16 firms
Hold1 buy · 15 hold · 0 sell
Avg. target $50.94 (+2.1%)
Prices may be delayed and are for informational purposes only - not investment advice.